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Objectives. This study sought o validate computerized vector- 
cardiography against the established technique of Holter electro- 
cardiographic (ECG) monitoring and to compare the feasibility of 
the two methods for monitoring patients with unstable angina 
pectoris. 
Background. Detection of myocardial ischemic episodes is an 
important objective in patients admitted to the hospital for 
unstable angina pectoris. Standard ECG monitoring may be 
sufficient for detection of symptomatic episodes but will often 
overlook silent ischemia. Holter ECG monitoring has a higher 
likelihood of discovering such episodes, but analysis is time- 
consuming, and the results are not available on-line. 
Methods. We simultaneously monitored 53 consecutive patients 
with unstable angina, 46 of whom had technically adequate 24-h 
Holter ECGs and computerized vectorcardiograms. 
Results. The Holter tapes had a mean (_+SD) of 15.3 + 10.3 h 
of recording with both channels technically adequate for analysis 
compared with 23.7 -+ 1.77 h of vectorcardiographic recording 
that could be analyzed (p < 0.01). Of the 15 symptomatic episodes 
detected by Holter ECG monitoring, 13 were also detected with 
dynamic vectorcardiography. In contrast, eight patients had 18 
episodes of chest pain, with simultaneous ST segment changes 
detected by dynamic vectorcardiography; only 9 of these episodes 
were also detected by Holter ECG monitoring. 
Conclusions. Monitoring of myocardial ischemia with dynamic 
vectorcardiography seems to be more efficient han Holter moni- 
toring and may have a higher sensitivity. Computerized, continu- 
ous vectoreardiography as a complete real-time capacity, allow- 
ing monitoring over prolonged periods of time, and the results are 
immediately available without time-consuming analysis. 
(JAm CoU Cardiol 1995;26:1501-7) 
Unstable angina is a condition caused by myocardial ischemia, 
characterized bysymptoms of recent onset, a crescendo pat- 
tern or the occurrence of symptoms atrest. Despite intensive 
medical treatment to control chest pain, approximately one- 
third of patients with unstable angina have an unfavorable 
outcome within a period of 2 months (1-3). During the acute 
hospital period, ordinary electrocardiographic (ECG) moni- 
toring in the coronary care unit may detect symptomatic 
episodes of myocardial ischemia. However, silent episodes may 
pass undetected. Continuous Holter ECG monitoring identi- 
fies silent episodes of myocardial ischemia in patients with 
unstable angina, thereby increasing the probability of obtaining 
more complete information on the pattern of disease and 
improved prognostic nformation (4,5). 
We previously described (6-8) the use of dynamic ontin- 
uous computerized on-line vectorcardiography to monitor 
patients with acute myocardial infarction as well as during 
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coronary angioplasty and unstable angina. With this technique, 
the dynamic ECG changes een during myocardial ischemia 
and infarction can be monitored in real time. Our previous 
experience with this technique indicated that dynamic vector- 
cardiography could improve detection of ischemia during 
monitoring of patients with unstable angina. 
The vectorcardiographic ST segment criteria used by us 
initially were shown to yield a significant incidence of apparent 
ischemic episodes in 20 healthy volunteers, that is, the speci- 
ficity of our criteria was poor. Reanalysis of our earlier data 
provided criteria with improved specificity for the original data 
set. The present study was performed to validate our new 
vectorcardiographic cr teria against the established technique 
of Holter ECG monitoring to compare the feasibility of 
dynamic vectorcardiography and Holter ECG monitoring in 
patients with unstable angina pectoris and, in addition, to 
evaluate the prognostic information obtained by the two 
monitoring systems. 
Methods  
Patients. Fifty-three consecutive patients with unstable an- 
gina admitted to the coronary care units of our hospitals 
underwent simultaneous Holter ECG monitoring and dynamic 
vectorcardiography. Informed oral consent was obtained from 
all patients before the procedure, and the protocol was ap- 
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proved by the ethics committee of the University of G~3teborg. 
In 7 patients either the Halter (5 patients) or the vectorcar- 
diographic data (1 patient), or both (1 patient), could not be 
analyzed for technical reasons, leaving 46 patients for inclusion 
in the final analysis (34 men, 12 women; mean [_+SD] age 64 +_ 
10 years, range 43 to 82). Unstable angina was defined as 
follows: 1) anginal pain commencing no longer than 4 weeks 
before admission or sudden deterioration ofa previously stable 
angina pectoris within the same time frame; 2) at least one 
episode of anginal chest pain within the past 24 h, each episode 
lasting <30 rain and strongly indicating ischemic heart disease 
but not acute myocardial infarction. Both criteria had to be 
fulfilled for inclusion. Furthermore, patients with bundle 
branch block (QRS width >0.12) and suspicion of unstable 
angina secondary to anemia, arrhythmias or heart failure were 
not included. 
Clinical course. Of the 46 patients included, 4 were dis- 
charged with a diagnosis of acute myocardial infarction, and 2 
with noncardiac hest pain; the remaining 40 had unstable 
angina. Medical treatment was given at the discretion of the 
responsible physician. Beta-adrenergic blocking agents were 
given to 40 of the 46 patients (87%), aspirin to 35 (76%), 
heparin to 15 (33%), long-acting nitrates to 24 (52%), intra- 
venous nitrates to 17 (37%) and calcium-channel b ocking 
agents to 13 (28%). Coronary angiography was performed in 
20 patients (43%) whose angina could not be stabilized by 
medical treatment within 2 to 3 days. Three of these patients 
had one-vessel disease (~50% narrowing), and eight each had 
two- and three-vessel disease. The final patient did not reveal 
any significant coronary stenosis. Revascularization was per- 
formed during the initial hospital phase in 14 of these 20 
patients (2 had angioplasty; 12 had coronary artery bypass 
grafting). The result of ischemia monitoring was not used for 
the decision to perform revascularization. Nineteen of the 26 
patients whose angina was stabilized by medical treatment 
underwent a submaximal exercise test before hospital dis- 
charge. The test results were suggestive of coronary artery 
disease in 13 and normal in 6 patients. Four of the six patients 
with normal results during exercise had changes on the rest 
ECG at admission, indicating coronary insufficiency, and two 
were discharged with a diagnosis of an extracardiac reason for 
the chest pain. The seven patients who did not perform an 
exercise test were all elderly. Two of them had a non-Q wave 
infarction, and one had chest pain with concomitant ECG 
changes, indicating myocardial ischemia. The remaining four 
patients had incapacitating illness, mostly orthopedic, limiting 
a bicycle exercise test. 
Halter ECG monitoring. Immediately on arrival at the 
coronary care unit, Halter ECG monitoring was initiated using 
a two-channel AM tape recorder (SpaceLabs 90205) con- 
nected to obtain bipolar leads corresponding tomodified leads 
V 1 and V5. The clock of the tape recorder was synchronized to
the clock of the vectorcardiographic computer, and the two 
devices were started simultaneously. All tapes were analyzed 
on a SpaceLabs Halter analyzer centrally at one of the 
participating hospitals (Karolinska). Ischemia was defined as 
ST segment depression >1 mm or elevation >2 mm continu- 
ously present for at least 60 s. Ischemic changes had to be 
separated by at least 60 s to be counted as two discrete 
episodes. All episodes of ST segment depression or elevation 
were printed out for manual check by a technician with no 
knowledge of any clinical or vectorcardiographic data from the 
patient. 
Dynamic veetoreardiography. Continuous on-line comput- 
erized vectorcardiographic monitoring was performed using a 
MIDA 1000 system (Ortivus Medical AB, T~iby, Sweden). The 
method has been described in detail elsewhere (9). Briefly, 
eight electrodes (seven plus one ground electrode) were 
positioned according to Frank (10), and three orthogonal leads 
(X, Y and Z) were continuously monitored and analyzed. After 
the operator has accepted the template beat as the normal beat 
for that patient, the computer automatically discards all beats 
with a grossly different configuration. Accepted beats are 
averaged every 30 s to form a mean beat for that period. The 
first two 30-s periods are used as the reference for all further 
comparisons. All calculations are done in real time. The result 
is presented on a computer screen, and changes are related to 
the initial reference mean beat for each patient o be presented 
over time as trend curves. The following vectorcardiographic 
variables were studied: QRS vector difference, ST segment 
vector magnitude 20 ms after the J point (STVM20), ST 
segment vector magnitude 60 ms after the J point (STVM60) 
and ST segment change vector magnitude. The QRS vector 
difference, ST segment vector magnitude and ST segment 
change vector magnitude are shown in Figure 1. 
Definitions. According to previous results (8) in a different 
group of (angina) patients and 20 normal control subjects, with 
some modifications, myocardial ischemia as detected by dy- 
namic vectorcardiography was defined as follows: 1) QRS 
vector difference = reversible increase to >15/xV for >1 min 
(i.e., lasting for two averaged periods); 2) STI/M20, STVM60 = 
reversible increase >50 ~V from the individual baseline for 
>1 min; 3) ST segment change vector magnitude = reversible 
increase >50 t~V for >1 rain. 
In patients with ongoing ischemia at the onset of the 
vectorcardiographic recording, an elevated baseline of the 
trend curve was observed as ischemia disappeared. Because of 
the differential nature of the QRS vector difference and ST 
segment change vector magnitude, in these patients disappear- 
ance of the ischemia would appear as an increase in both 
variables, whereas a subsequent recurrent ischemic episode 
may appear as a decrease. In such patients ischemic hanges in 
the QRS vector difference were defined as follows: any revers- 
ible change >10/sV from a new baseline stablished for the 
individual patient and defined as a stable QRS vector differ- 
ence >1 h. 
For the ST segment change vector magnitude a new 
baseline was established in the same way, and any change 
>50/~V was defined as ischemic if it was reversible. Tentative 
ischemic episodes defined by dynamic vectorcardiography were 
compared with episodes occurring simultaneously on Halter 
ECG monitoring. A limit of ->50% concordance was chosen; 
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Figure 1. Top panel, Trend curve for time 
versus vectorcardiographic variables (vertical 
axis) showing an ischemic episode. Below, the 
average QRS complex from peak ischemia is
plotted (thick line) on the average QRS com- 
plex from a period of nonischemia (thin line). 
Shaded area of difference between the two 
complexes, summed for leads X, Y and Z, is 
the QRS vector difference (QRS-VD). Middle 
panel, ST segment vector magnitude (ST-VM) 
shown at peak ischemia. ST segment deviation 
at either 20 or 60 ms beyond the J point is 
measured and summed for all three leads, 
forming the ST segment vector magnitude. 
Bottom panel, ST segment change vector mag- 
nitude for ischemic and nonischemic condi- 
tions. When summed for the three planes, the 
vector connecting the tips of the two vectors 
forms the summated STsegment change vec- 
tor magnitude (STC). 
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that is, if during an ischemic episode detected by one method, 
changes were also observed on the other monitoring system for 
at least 50% of the time, the two methods were considered 
concordant for that particular episode. 
Symptoms. Each hour the patients were asked by the 
attending nurse about he occurrence, severity and duration of 
any chest pain during the preceding hour. The patients were 
asked to grade the severity on a visual analogue scale from 0 
(no pain at all) to 10 (unbearable pain). 
Follow-up. All patients were followed up for at least 1 year 
after inclusion in the study. The hospital records of all patients 
were checked for occurrence ofnonfatal myocardial infarction 
and hospital admissions for heart failure, unstable angina or 
revascularization. 
Statistics. Results are given as mean value + SD, unless 
otherwise indicated. Paired Student t test and Wilcoxon rank- 
sum test were used as appropriate. Proportions were compared 
using a chi-square test with continuity correction when indi- 
cated. Simple linear regression was used to assess correlation. 
A p value <0.05 was considered significant. 
Resu l ts  
Feasibility of Holter ECG and vectorcardiographic moni- 
toring. The Holter tapes had an average of 15.3 _+ 10.3 h of 
recording with both channels technically adequate for analysis 
compared with 23.7 + 1.77 h of vectorcardiographic re ording 
that could be analyzed (p < 0.01). At least one channel could 
be analyzed for an average of 22.8 + 5.67 h on the Holter 
recordings (p = 0.06 vs. vectorcardiography). 
Overall results of Holter ECG and vectorcardiographic 
monitoring. The mean number of ischemic episodes and 
mean total duration of tentative ischemic episodes are shown 
in Table 1. Results are presented for each vectorcardiographic 
variable, along with the proportion of silent versus ymptom- 
atic episodes. Although Table 1 shows the mean number and 
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Table 1. Number of Ischemic Episodes and Mean Duration of Ischemia As Defined by Holter 
Electrocardiographic Monitoring and Dynamic Vectorcardiography 
Vectorcardiography* 
Holter ECG STVM20 STVM60 STC-VM QRS-VD 
No. of episodes 
Mean -+ SD 1.5 _+ 3.2 1.5 +_ 3.9 1.8 + 4.3 3.6 _-. 5.3 9.4 _+ 6.3 
Median 0 0 0 1 9 
% silent 78 78 76 84 91 
Duration of ischemia (min) 
Mean _+ SD 57 _+ 202 19 --- 67 24 - 80 35 + 72 188 _+ 179 
Median 0 0 0 2 131 
% silent 88 69 69 77 95 
No. (%) of pts with ->1 episode 14 (29) 12 (24) 12 (24) 25 (53) 43 (93) 
*See Methods for more precise definition ofvectorcardiographic var ables u ed. ECG = electrocardiography; pts = 
patients; QRS-VD = QRS vector difference; STC-VM = ST segment change vector magnitude; STVM20 = ST segment 
vector magnitude 20ms after the J point; STVM60 = ST segment vector magnitude 60ms after the J point. 
duration of ischemic episodes per patient for all 46 patients, 
the number of patients who actually had at least one episode as 
defined by each variable is also shown. 
Episodes of symptomatic ST segment depression/elevation 
on Holter ECG monitoring. Six patients had a total of 15 
episodes of chest pain with simultaneous ST segment depres- 
sion/elevation on Holter ECG monitoring. Mean duration of 
symptomatic ischemia per patient was 51 - 31 min. Of the 15 
symptomatic episodes detected by Holter ECG monitoring, 13 
were also detected with dynamic vectorcardiography, I was not 
detected by vectorcardiography, and during 1 episode the 
vectorcardiographic re ording could not be analyzed for tech- 
nical reasons. 
Episodes of symptomatic isebemic changes on vectorcar- 
diography. There were 15 episodes in seven patients of chest 
pain with simultaneous changes in STVM20; 9 of these epi- 
sodes were also detected by Holter ECG monitoring. For 
STVM60, the corresponding results were 18 episodes in 8 
patients, 9 also detected by Holter ECG monitoring; for ST 
segment change vector magnitude, 25 episodes in 12 patients, 
9 also detected by Holter ECG monitoring; and for ORS 
vector difference, 35 episodes in 16 patients, 6 episodes also 
detected by Holter ECG monitoring. 
Correlation between Holter ECG monitoring and vector- 
cardiography. Correlation between Holter ECG monitoring 
and the various vectorcardiographic variables for total number 
and duration of episodes are shown in Table 2. The correlation 
between episodes of symptomatic ST segment depression on 
Holter ECG monitoring and symptomatic episodes detected by 
dynamic vectorcardiography arepresented in Table 3. Figures 
2 and 3 show the vectorcardiographic and Holter ECG record- 
ings from patients with an episode of chest pain. In Figure 2, 
the episode was accompanied by significant ST segment de- 
pression on Holter ECG monitoring as well as changes in ST 
segment vector magnitude above the detection limit for isch- 
emia. In Figure 3, the episode is accompanied by ST segment 
vector magnitude changes but only slight changes on Holter 
ECG monitoring, not fulfilling the criteria for ischemic hange. 
Correlation between ST segment variables. The correla- 
tion for number of episodes and for duration between 
STVM20 and STVM60 were 0.967 and 0.713. Generally, the 
STVM60 episodes were somewhat longer, although the differ- 
ence was not significant. 
Prognosis in relation to Holter ECG monitoring and vec- 
torcardiography. During 1-year follow-up there were four 
deaths, all from cardiac causes, and four nonfatal infarctions. 
The outcome during 1-year follow-up in relation to results of 
ischemia monitoring during the initial hospital period are 
shown in Table 4. The occurrence of at least one episode of 
ischemia s detected by Holter ECG monitoring identified 2 of 
8 patients with and 11 of 38 without subsequent events. At least 
one episode of ischemia as detected by dynamic vectorcar- 
diography was found in 6 of 8 patients versus 5 of 38 patients 
without events. Nine patients had a total duration of ischemia 
>60 mm on Holter ECG monitoring, two of whom had an 
event during follow-up, but seven did not. Similarly, at a cutoff 
point >20 min, myocardial ischemia as detected by dynamic 
vectorcardiography occurred in five patients, two of whom 
subsequently had an event. 
Table 2. Coefficients of Correlation Between Ischemic Episodes 
(symptomatic and silent) Defined by Holter Electrocardiographic 
Monitoring and Dynamic Vectorcardiography 
Holter ECG 
Vectorcardiographic No. of Total 
Variable Episodes Duration 
STVM20 0.644 0.540 
STVM60 0.757 0.808 
STC-VM 0.696 0.784 
QRS-VD 0.365 0.202 
Abbreviations a  in Table 1. 
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Table 3. Coefficients of Correlation Between Symptomatic Ischemic 
Episodes Defined by Holter Electrocardiographic Monitoring and 
Dynamic Vectorcardiography 
Holter ECG 
Vectorcardiographic No. of Total 
Variable Episodes Duration 
STVM20 0.821 0.925 
STVM60 0.747 0.798 
STC-VM 0.863 0.838 
ORS-VD 0.213 0.191 
Abbreviations a  in Table 1. 
Discuss ion  
An increased understanding of the process of evolving 
myocardial infarction as a result of unstable atherosclerotic 
coronary artery plaques and improved techniques of revascu- 
larization have resulted in more patients with unstable angina 
pectoris being monitored in the coronary care unit. An impor- 
tant goal of such monitoring is to detect as many myocardial 
ischemic episodes as possible. Symptomatic episodes are usu- 
ally not difficult to discover by ordinary ECG monitoring. 
However, many episodes are silent and may go undetected. 
Dynamic vectorcardiography is a new technique for monitor- 
ing myocardial ischemia. Previous reports of this technique 
(6,11-13) focused on patients with acute myocardial infarction, 
but only one study (8) dealt with unstable angina. In contrast, 
Holter ECG monitoring has been extensively used and docu- 
mented in stable as well as unstable angina. Thus, Holter ECG 
monitoring presently represents the reference standard for 
monitoring ischemia, against which new monitoring techniques 
should be validated. The present study sought to relate the 
results of this new technique of continuous computerized 
vectorcardiography to the present standard. 
Yectoreardiography versus Holter ECG monitoring. The 
feasibility of the two systems was generally high, but vector- 
cardiography ielded significantly more time with complete 
information. In addition, the MIDA system offered on-line 
analysis with relatively little system-operator interaction, 
whereas Holter ECG monitoring required time-consuming 
retrospectively performed analysis. 
With dynamic vectorcardiography we identified 13 of the 15 
episodes of symptomatic ST segment depression/elevation 
Figure 2. Vectorcardiographic and Holter recordings from a patient 
with an episode of chest pain (dashes). This episode is accompanied by
ischemic hanges detected by both monitoring systems. STVM = ST 
segment vector magnitude 20 ms after the J point. 
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Figure 3. Vectorcardiographic and Holter recordings from a patient 
with an episode of chest pain (dashes). This episode is accompanied by
ischemic hanges detected by dynamic vectorcardiography, but the 
Holter recording shows <1 mm ST segment elevation in both leads 
(only one lead shown), not identifying the episode as ischemic. STVM = 
ST segment vector magnitude 20 ms after the J point. 
recorded by Holter ECG monitoring. Importantly, only one 
episode of ischemic changes and concomitant chest pain 
occurred without being observed on the vectorcardiographic 
system. The opposite was more frequent, with only 9 of 15 
symptomatic STVM20 episodes and 9 of 18 STVM60 episodes 
also detected by Holter ECG monitoring. Thus, it can be 
argued that vectorcardiography will detect ischemia with a 
higher sensitivity than Holter ECG monitoring. Whereas epi- 
sodes of ST segment depression/elevation on Holter ECG 
monitoring occur in both asymptomatic patients and normal 
control subjects (14), symptomatic ST segment depression/ 
elevation is most likely an expression of myocardial ischemia, 
given the patients in the present study. With dynamic vector- 
cardiography we were able to identify several episodes of 
symptomatic ST segment changes without concomitant 
changes on the Holter ECG. Dynamic vectorcardiography 
reflects all changes on all ECG leads, whereas Holter ECG 
monitoring usually reflects changes on only one or two leads, in 
our case modified leads V1 and Vs. The usefulness of any 
monitoring device depends on both sensitivity and specificity, 
but data regarding the specificity of dynamic vectorcar- 
diography are very limited (8,15). The clinical value of our 
observations cannot be fully appreciated at present. 
There are several studies (16-18) of ECG monitoring 
during coronary angioplasty in which Holter monitoring iden- 
tified only some, but not all, ischemic episodes during balloon 
inflation. Other multilead ECG monitoring systems, such as 
Table 4. Outcome During 1-Year Follow-Up in Relation to Results 
of Ischemia Monitoring During Initial Hospital Period 
Pts Without Pts With Nonfatal 
Events AMI or Death p 
(n = 38) (n = 8) Value 
No. of episodes ofchest pain 2.9 _+ 4.3 3.0 -+ 2.3 NS 
Holter ECG 
No. of ischemic episodes 1.5 _+ 3.1 1.8 _+ 3.9 NS 
Duration of ischemia 31 _+ 70 180 _+ 457 NS 
Vectorcardiography (STVM20) 
No. of episodes 1.1 + 3.4 3.5 + 5.6 <0.01 
Duration of ischemia 15 - 65 40 __. 80 <0.05 
Data presented are mean value -L-_ SD. AMI = acute myocardial nfarction; 
other abbreviations as in Table 1. 
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continuous 12-lead electrocardiography, will most likely per- 
form better than two-channel Holter monitoring. However, no 
controlled trial comparing Holter monitoring and continuous 
12-lead electrocardiography has been performed in patients 
with unstable angina. 
Vectorcardiographic variables. Of the ST segment vari- 
ables monitored by the MIDA system, STVM60 most closely 
resembles ST segment analysis by Holter ECG monitoring. 
The ST segment change vector magnitude also accounts for 
spatial changes. The ST segment change vector magnitude 
indicated ischemia more frequently than either the Holter 
ECG monitoring or conventional ST segment variables derived 
by continuous vectorcardiography (Table 1). This finding is in 
accord with results from animal studies (19) of closed chest 
coronary artery occlusion model in which the ST segment 
change vector magnitude was more reliable than the ST 
segment vector magnitude as an indicator of ischemia. In a 
previous tudy (8) in 20 healthy control subjects, we found the 
specificity of ST segment change vector magnitude to be high, 
without any false positive findings during a 12-h period of 
continuous vectorcardiographic monitoring. The ST segment 
change vector magnitude therefore seems to have significant 
potential for future improved and more sensitive monitoring of 
ischemia. 
The QRS vector difference indicated substantially more and 
longer episodes of ischemia, of which a larger proportion were 
silent. Several investigators (7,20) have reported QRS changes 
as a result of reversible myocardial ischemia. During coronary 
angioplasty, QRS changes eem to be a highly sensitive but less 
specific indicator of myocardial ischemia than ST segment 
monitoring. Apart from ischemia, several factors, such as 
changes in body position, profoundly affect the QRS vector. 
These factors currently limit practical use of this variable for 
long-term monitoring of myocardial ischemia. The clinical 
value of the vectorcardiographic monitoring system could be 
enhanced by some type of indicator of change of body position. 
We previously published (8) criteria for detection of isch- 
emia with dynamic vectorcardiography based on different 
patients than our present group. Among those patients a 
change in STVM20 of 100 /zV resulted in relatively low 
sensitivity and specificity. The reason for lack of specificity was 
that the ST segment vector magnitude in many patients 
without ischemia is close to 100 ~V. A slight change in body 
position may then increase the ST segment vector magnitude 
to >100/xV, falsely indicating ischemia. The present criteria 
seem to perform better but should be further validated, most 
notably in healthy volunteers with a low prevalence of myocar- 
dial ischemia. In our previous data set, which included 20 
healthy volunteers monitored for 12 h, the 50-/xV criterion 
gave no false positive results. The use of the subject's own 
baseline as reference for further ECG changes seems to 
improve the specificity of continuous vectorcardiography in 
this setting. This result may also hold true for Holter monitor- 
ing and other types of two- or three-lead monitoring systems 
but needs to be explored further before being adopted for 
clinical practice. 
Prognostic value. In the present study we found a 1-year 
mortality rate of 8%, and a total of 16% of patients had a 
nonfatal myocardial infarction or died during the 1-year follow- 
up period. Holter monitoring has been used extensively to 
identify patients who are at an increased risk for an event 
(5,21). In accord with previous reports, we found that nonfatal 
acute myocardial infarction or death during follow-up tended 
to be associated with an increased number of episodes and a 
longer total duration of ischemia as detected by Holter ECG 
monitoring. This relation was statistically significant when 
dynamic vectorcardiography was used for detection of isch- 
emia in the same patients. Neither the occurrence of ischemic 
episodes nor the total duration of ischemia as detected by 
Holter ECG monitoring was able to identify those patients 
who subsequently experienced an event during follow-up. This 
result is in contrast to previous findings, but it is not surprising 
for the limited number of patients in the present study. In 
contrast, dynamic vectorcardiography correctly identified 6 of 
8 patients with a subsequent event, even though 11 of 38 
patients without an event also had ischemic episodes detected 
by dynamic vectorcardiography. 
Conclusions. Monitoring of myocardial ischemia with dy- 
namic vectorcardiography seems to be more efficient than 
Holter monitoring with regard to sensitivity for ischemia 
detection. The specificity of the system remains to be further 
explored. The presently used computerized vectorcardio- 
graphic system has a complete real-time capacity allowing 
monitoring during prolonged periods of time. The results are 
immediately available for clinical decision making without any 
preceding or time-consuming analysis. Presently, the system 
can be used only in patients during bed rest. It is suitable for 
patients admitted to the hospital for suspected acute myocar- 
dial infarction or unstable angina. 
The time-consuming and difficult ask of analyzing Holter recordings was 
expertly performed by technician Barbro Kjellstrrm. We also acknowledge the 
assistance of the staff at the coronary care unit at Karolinska Hospital and at 
Ostra Hospital. 
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